Filing Flows › Tenaya Therapeutics (TNYA) › Who owns the stock
Who owns Tenaya Therapeutics (TNYA) stock
96 funds reported Tenaya Therapeutics (TNYA) shares in their latest 13F filings, worth $45.3M in all. The largest holder is Vanguard Group ($6.1M). Last quarter 45 funds added to their stakes and 36 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Group | 8,560,108 | $6.1M | increase | 2025-12-31 |
| Vanguard Capital Management LLC | 7,101,263 | $5.2M | decrease | 2026-06-30 |
| Millennium Management LLC | 6,429,648 | $4.8M | increase | 2026-06-30 |
| Citadel Advisors LLC | 4,566,774 | $3.4M | increase | 2026-06-30 |
| Renaissance Technologies LLC | 4,281,100 | $3.2M | increase | 2026-06-30 |
| BlackRock | 4,008,719 | $3.0M | increase | 2026-06-30 |
| Empery Asset Management, LP | 3,863,115 | $2.9M | decrease | 2026-06-30 |
| Marshall Wace, LLP | 3,503,178 | $2.6M | increase | 2026-06-30 |
| GSA Capital Partners LLP | 2,669,033 | $2.0M | increase | 2026-06-30 |
| Burkehill Global Management, LP | 2,000,000 | $1.5M | unchanged | 2026-06-30 |
| Geode Capital Management, LLC | 1,834,674 | $1.4M | increase | 2026-06-30 |
| ADAR1 Capital Management, LLC | 1,555,500 | $1.1M | increase | 2026-06-30 |
| Raiffeisen Bank International AG | 1,200,000 | $882K | increase | 2026-06-30 |
| Euclidean Capital LLC | 1,015,705 | $751K | unchanged | 2026-06-30 |
| Vanguard Fiduciary Trust | 987,505 | $730K | decrease | 2026-06-30 |
Tenaya Therapeutics' latest quarter
Tenaya Therapeutics, Q3 2026: revenue $1.7M, net loss $18.9M, operating cash flow −$17.7M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most TNYA stock?
By the latest 13F filings: Vanguard Group ($6.1M); Vanguard Capital Management LLC ($5.2M); Millennium Management LLC ($4.8M); Citadel Advisors LLC ($3.4M); Renaissance Technologies LLC ($3.2M).
What is the short interest in TNYA?
22,517,147 shares were sold short at the 2026-10-15 settlement, -1.77% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.